NAGE Q2 2019 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

Q2 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+42.3% YoY

Gross Profit

$6M56.3% margin

Operating Income

-$7M-64.7% margin

Net Income

-$8M-69.9% margin

EPS (Diluted)

$-0.14

QoQ Revenue Growth

+10.5%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$45M

Total Liabilities

$29M

Stockholders' Equity

$15M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$8M	+42.3%
Gross Profit	$6M	$4M	+62.6%
Operating Income	-$7M	-$8M	+9.5%
Net Income	-$8M	-$8M	+3.7%